Epidemiology
Raised intracranial pressure (ICP) is the final common pathway for many intracranial problems (table 1) and has a profound influence on outcome. For example, of the 3-500 000 patients with head injury seen in Accident and Emergency Departments in the United Kingdom per annum, 20% are admitted of whom 10% are in coma (2% of all attenders). Over 50% of these have an intracranial pressure greater than 20 mm Hg.'2 A total of 80% of patients with fatal head injuries (4% of all patients with head injuries admitted) show evidence of a significant increase in intracranial pressure at necropsy. Some 35% of severe head injuries die and 18% are left severely disabled at enormous financial and emotional cost to the family and community. Similarly, 20 per 100 000 per year are admitted with intracerebral haematoma and 10-12 per 100 000 per annum with subarachnoid haemorrhage. The average regional neurosurgical unit serving a population of two million will manage 200 patients per annum with brain tumours, some 15 patients with chronic subdural haematoma, and a similar number of patients with a cerebral abscess and 50 patients with hydrocephalus.3 In comatose children the incidence of raised ICP was 53% of those with head injuries, 23% with anoxicischaemia damage, 66% with meningitis, 57% with encephalitis, 100% The 'four-lump' concept describes most simply the causes of raised ICP: the mass, CSF accumulation, vascular congestion and cerebral oedema (table 2) .>7 The description of a patient with raised ICP as having cerebral congestion, vasogenic oedema etc, can only be a working approximation, albeit useful, until our rather crude methods of assessment are refined. In adults, the normal ICP under resting conditions is between 0-10 mmHg with 15 mmHg being the upper limit of normal. Active treatment is normally instituted if ICP exceeds 25 mmHg for more than 5 minutes although a treatment threshold of 15-20 mmHg has been suggested to improve outcome. 8 In the very young, the upper limit of normal ICP is up to 5 mmHg.9 Small increases in mass may be compensated for by reduction in CSF volume and cerebral blood volume but, once such mechanisms are exhausted, ICP rises with increasing pulse pressure and the appearance of spontaneous waves (plateau and B waves).10 There is an exponential relationship between increase in volume of an intracranial mass and the increase in intracranial pressure at least within the clinically significant range.
Cerebral perfusion pressure is commonly defined as: CPP = mean arterial blood pressure-mean ICP; mean ICP closely approximates to mean cerebral venous pressure. As cerebral perfusion pressure (CPP) falls with increasing ICP, ICP pulse pressure increases (fig 1) .1 12 Firstly, the brain is less compliant or stiffer and a given pulsatile cerebral blood volume load provokes a bigger pressure response. Secondly, the pulsatile component of cerebral blood flow increases with decreasing CPP. Cerebral arteriolar dilatation to maintain cerebral perfusion ('autoregulation') may be involved. The lower limit of CPP which will permit autoregulation, when ICP is raised, is about 40 mmHg. However, there is a paradox: the level of CPP below which outcome after severe head injury and associated parameters deteriorate is of the order of 60-65 mmHg (MAP < 80 mmHg; ICP > 20 mmHg). Conventionally any elevation of ICP requires treatment if CPP is below 60 33 The problem has been that it is a big tube technique that measures flow velocity in branches of the Circle of Willis, most commonly the middle cerebral artery. Changes in velocity may reflect either changes in blood flow or in diameter of the insonated artery. Unfortunately, diameter and flow may not change in complementary directions and great care must be taken with the interpretation.34 Low velocity may indicate low flow or arterial dilatation at constant flow. High velocity may indicate high flow or arterial constriction/vasospasm at constant flow. Considerable ingenuity has been expended in analysis of a TCD wave form. The amplitude of the flow velocity pulse wave (FVa) reflects pulsatile changes in regional CBF and is dependent on the amplitude of the arterial pressure wave, regional cerebrovascular resistance, the elastance of the capillary bed and the basal cerebral arteries. Aaslid suggested that an index of CPP could be derived from the ratio of the amplitudes of the first harmonics of the arterial blood pressure and of the middle cerebral artery velocity (detected by TCD) multiplied by mean flow velocity. There is a reasonable correlation between the pulsatility index (peak systolicend diastolic FV's/time averaged FVm) of MCA velocity and CPP after head injury but absolute measurements of CPP cannot be extrapolated. 35 Dehydration increases the risk of hypovolaemia which may be revealed only when the patient is given an anaesthetic agent, for example, for an orthopaedic procedure or as part of a regime to control raised ICP. A stable circulation must be maintained,53 if necessary with colloid and inotropes (dobutamine or dopamine for its renal sparing action). However, overenthusiastic hypertensive-hypervolaemic therapy remains very controversial in the context of head injury with its multiple pathology and uncertainty over the integrity of the blood-brain barrier.5456 Systemic hypertension should not be treated directly with agents such as sodium nitroprusside. Sodium nitroprusside impairs autoregulation and increases the risk of boundary zone infarction. 57 The cause of hypertension, for example, pain or retention of urine, should be looked for.
The majority of neurosurgical patients with hyponatraemia do not have inappropriate secretion of ADH and it is unwise to use fluid restriction to treat them even if they do. 51 58 A useful dictum in neurosurgery is that blood volume comes before plasma sodium levels. Moderate hyponatraemia impairs cerebrovascular reactivity experimentally to both hypercapnia and hypotension but does not augment the cerebrovascular effects of experimental SAH.59 A spectrum of abnormalities give rise to hyponatraemia following SAH, for example: initial natriuresis leading to volume depletion, ADH secretion stimulated both by stress and volume depletion, ADH-induced water retention, steroid-and sympatheticinduced effects on the kidney and possible release of atrial natriuretic factor (both cardiac and cerebral in origin) and digoxin-like substance.
Seizures may be difficult to recognise when the patient is paralysed and ventilated. Episodes of pupillary dilatation with increases in arterial blood pressure and ICP are suggestive.
Pyrexia not only increases cerebral metabolism and hence cerebral vasodilatation but also cerebral oedema. Severe hypothermia was used historically to treat raised ICP but it has become clear more recently that mild hypothermia of a few°C only will reduce cerebral ischaemia for reasons that hyperventilation may precipitate cerebral ischaemia with EEG slowing, CSF lactic acidosis and a cerebral arterio-venous oxygen content difference > 9 ml/dl. Arterial blood pressure may be reduced by the combination of dehydration and aggressive hyperventilation. Finally, weaning from the ventilator may be more difficult and prone to "rebound" intracranial hypertension: the brain's buffering mechanisms have to readjust back again. Finally, cerebrovascular reactivity to CO2 may be absent in some patients after head injury, but such reactivity is seldom measured before hyperventilation is started. TCD is a simple way of assessing CO2 reactivity. In one study, controlled hyperventilation used prophylactically did not improve outcome but did prolong the recovery phase. 88 Hence there is growing awareness that hyperventilation be used sparingly, for example, to treat persistent ICP waves.
CSF lactate accumulation and CSF acidosis occur after head injury.89 90 Both severity of injury and the proportion of patients with a poor outcome are related to high and increasing CSF lactate levels. Cerebral tissue lactic acidosis is related to secondary brain damage following a primary insult such as cerebral ischaemia even if moderate acidosis per se has no persisting effect on normal neurons.
Akiota et a19' found that the intravenous buffer tris hydroxymethyl aminomethane (THAM) ameliorated both the CSF acidosis and brain swelling following epidural balloon compression of the brain in dogs. In 1970, Gordan and Rossanda92 suggested that hyperventilation might be beneficial as the result of compensation of CSF acidosis but only at very low arterial pCO2 (20) (21) (22) (23) (24) (25) that is now proposed to produce severe cerebral vasoconstriction and in some individuals cerebral ischaemia. THAM, after intravenous administration, equilibrates with the intracellular and extracellular spaces in the body as well as with CSF. Evidence is accumulating both experimentally and in humans that THAM is at least as effective as mannitol in reducing experimental oedema in the brain and lowering ICP after head injury.93 94 THAM reduces the demand for mannitol and CSF drainage. In the most recently published randomised prospective clinical trial,94 a total of 149 patients with severe head injury (Glasgow Coma Scale < 8) were randomly assigned to either a control or a THAM group. Both groups of patients matched in terms of clinical parameters including age, sex, number of surgical mass lesions, number in each Glasgow scale stratum and the first ICP measurement. All patients were treated by standard management protocols, intubated, mechanically ventilated, and maintained in the PaCO, range of 32-35 mm Hg for 5 days. THAM was administered as a 0-3 M solution in an initial loading dose (body weight x blood acidity deficit, average 4-27 cc/kg/hour) given over two hours, followed by constant infusion of lml/kg/hour for five days. Outcome was measured at three, six and 12 months post injury. Although analysis indi-cated no significant difference between these two groups at three months, six months or one year, there was a difference regarding ICP. The time that ICP was above 20 mmHg in the first 48 hours after injury was less in patients treated with THAM. Also the number of patients requiring barbiturate coma was significantly less in the THAM group (5-5% versus 18-4%). The authors concluded that THAM ameliorated the deleterious effects of prolonged hyperventilation, was beneficial in ICP control and further study of dose and timing of administration was warranted.
The cerebrovascular response to hypercapnia may be manipulated in other ways. It has been known since 1973 that the cerebrovascular CO2 response is blocked by indomethacin in doses that partly inhibit brain cyclo-oxygenase activity in vivo. 95 Cerebral venous pressure is very significantly reduced suggesting that ICP is reduced. That observation was not used clinically because of fear that indomethacin was inhibiting production of prostacyclin and that might be counterproductive. Certainly, cerebral oxygen delivery is seriously impaired when indomethacin is given to very young animals or to very pre-term infants undergoing treatment for patent ductus arteriosus.96 However, in five patients with injury with cerebral contusion and oedema in whom it was not possible to control ICP by hyperventilation and barbiturate sedation, indomethacin (bolus injection of 30 mgs followed by 30 mg/hour for 7 hours) reduced ICP below 20 mmHg for several hours.97 CBF was reduced at two hours without any changes in cerebral arteriovenous oxygen or lactate differences. Rectal temperature also fell from 38-6 to 37T3°C.
Hence a more substantial trial of indomethacin appears warranted, perhaps avoiding young children until further experience is accumulated. Inhibition of nitric oxide synthesis also blocks the cerebrovascular CO, response but may also increase focal cerebral infarction in the rat middle cerebral occlusion model. Hypnotic agents depress cerebral oxidative metabolism and hence lower CBF, CBV and ICP. However, cerebral electrical activity and normal coupling mechanisms between metabolism and flow must be present if barbiturates are to lower ICP.14'542 Normal flow metabolism coupling mechanisms may be assessed by the cerebrovascular response to CO2. Short-term protection during aneurysmal surgery with barbiturate or propofol is widely used. Synergy with even moderate hypothermia may be helpful provided MAP is maintained. 42 After initial reports of the effectiveness of short acting barbiturates in lowering ICP after head injury, three controlled trials have failed to show any overall significant improvement of outcome or reduction in number of patients dying with intracranial hypertension."11l16 Such trials involved heterogeneous groups of patients, however, and a treatment benefit in a sub group may have been missed.
Continuous
In the UK, althesin has been withdrawn even though its idiosyncratic allergic problems would not have been a contra-indication in the intensive care environment. Etomidate blocks steroidogenesis but it is apparently still used in the USA as an intraoperative protection agent by combining it with dexamethasone postoperatively for a few days."17 Gammahydroxybutyrate drops blood pressure and its administration involves a considerable sodium load."18 Propofol (di-isopropylphenol) is widely used but care has to be taken to avoid hypotension. Propofol also has free radical scavenging effects.' 9 The ideal hypnotic agent awaits development. In the patient with cardiovascular instability, lignocaine (1 -5mg/kg iv) may have a place in lowering ICP. '20 This dose is as effective as thiopentone (3mg/kg iv).
Epilepsy has long been known to increase ICP and increase the risk of cerebral ischaemia as a result of a massive increase in cerebral electrical activity and oxidative metabolism: both metabolic demand and CPP are embarrassed. Seizures must be treated aggressively. Over the last decade, however, a more focal phenomenon has been revealed: inappropriate hypermetabolism in small areas of the brain in association with local release or failed reuptake of excitotoxic amino acids such as glutamate.'2' 122 For example, subdural haemorrhage in the rat is accompanied by increased glutamate concentrations in the hippocampus with increased local cerebral glucose utilisation and late ischaemic brain damage. An NMDA antagonist will protect against such damage'23 just as NMDA antagonists reduce delayed neuronal loss and the volume of cerebral infarction after middle cerebral artery occlusion, provided such agents are given prophylactically or in some cases within an hour of occlusion. '24 125 The therapeutic window of opportunity is very short unless it is surmised that glutamate release occurs at various times after a head injury, not just at the moment of impact. Such impressive experimental data has led to Phase I and II trials of glutamate receptor antagonists in patients after severe head injury. The results are awaited with keen interest. Ironically, that old-fashioned treatment for severe head injuries-rectal magnesium chloride-is now known to be a noncompetitive NMDA receptor antagonist and reduces the infarct volume after middle cerebral occlusion in the rat. '26 Targetted therapy It is clear that there are many causes of raised ICP. The Edinburgh school has attempted7 to define which therapy should be selected for each cause of intracranial hypertension. They suggest that hypnotic agents may be most logically targetted at younger patients with diffuse congestive brain swelling with preserved cerebral electrical activity, jugular venous oxygen saturation over 75%, a pulserespiratory ratio in the ICP trace of over 2, preserved CBF CO2 reactivity and absence of a diastolic notch on TCD recordings of MCA velocity. Mannitol may be best used in patients of any age with focal lesions, a low cerebral perfusion pressure and reasonably preserved autoregulation. If arterial blood pressure is low despite colloid then inotropic agents such as Dobutamine or dopamine should be used. SAH with raised ICP is best managed by CSF drainage accepting that there is probably an increased risk of rebleeding.
Children
The management of raised ICP in childhood must take account of a number of factors.4 127 The critical values for ICP, ABP and CPP are lower, the younger the child. The normal ICP in the newborn is probably of the order of [2] [3] [4] 
Summary
This review has been written at an unfortunate time. Novel questions are being asked of the old therapies and there is an abundance of new strategies both to lower ICP and protect the brain against cerebral ischaemia. In the United Kingdom, the problem is to ensure that appropriate patients continue to be referred to centres where clinical trials of high quality can be undertaken. One of the success stories of the past decade has been the decline in the number of road accidents as a result of seat belt legislation, improvements in car design and the drink/driving laws. Hence, fortunately there are fewer patients with head injuries to treat and it is even more important that patients are appropriately referred if studies to assess efficacy of the new strategies are not to be thwarted. The nihilistic concept that intensive investigation with ICP monitoring for patients with diffuse head injury or brain swelling following evacuation of a haematoma or a contusion has no proven beneficial effect on outcome, requires revision. A cocktail of therapies may be required that can be created only when patients are monitored in sufficient detail to reveal the mechanisms underlying their individual ICP problem.
Ethical problems may arise over how aggressively therapy for intracranial hypertension should be pursued and for how long. There has always been the concern that cranial decompression or prolonged barbiturate coma may preserve patients but with unacceptably severe disability. Some patients may be salvaged from herniating with massive cerebral infarction with the use of osmotherapy but is the outcome acceptable?"30 Similar considerations apply to some children with metabolic encephalopathies. Where such considerations have been scrutinised in patients with severe head injury, the whole spectrum of outcomes appears to be shifted so that the number of severe disabilities and persistent vegetative states are not increased. However, it is important to be sensitive to such issues based on experience of the particular cause of raised intracranial pressure in a given age group.
